Equities

CellSource Co Ltd

4880:TYO

CellSource Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,275.00
  • Today's Change13.00 / 1.03%
  • Shares traded57.70k
  • 1 Year change-50.62%
  • Beta0.8373
Data delayed at least 20 minutes, as of May 31 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

  • Revenue in JPY (TTM)4.62bn
  • Net income in JPY851.00m
  • Incorporated2015
  • Employees151.00
  • Location
    CellSource Co Ltd2FShibuya Mitake Bldg., 1-19-5, ShibuyaSHIBUYA-KU 150-0002JapanJPN
  • Phone+81 364555308
  • Fax+81 364555968
  • Websitehttps://www.cellsource.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
As Partners Co Ltd17.15bn563.57m7.02bn835.0011.992.8412.370.4091164.64164.645,010.38695.30----------------18.13--3.29--0.876815.560.7039--34.17--145.34------
Care Twentyone Corp42.07bn-38.76m7.29bn5.91k--1.244.820.1732-2.87-2.873,121.08395.281.17749.337.537,123,649.00-0.12241.48-0.17351.9621.6622.97-0.10441.431.03-0.85880.785737.347.037.89-99.02-50.6624.669.43
Uchiyama Holdings Co Ltd28.84bn213.92m7.42bn2.33k31.020.53728.710.257111.0611.061,490.07638.540.9427102.3211.39--0.6992-2.040.9815-2.767.295.430.7417-2.271.5922.360.5216--7.181.17153.40-27.96-9.990.00
Advantage Risk Management Co., Ltd.7.00bn505.58m8.17bn391.0015.611.9811.941.1730.2930.29419.43238.511.12--6.76--8.097.7212.3812.1570.4974.077.227.42----0.079740.089.267.4033.89-3.8436.783.71
Japan Hospice Holdings Inc10.35bn669.37m12.25bn963.0018.134.1811.061.1882.0682.061,267.69355.740.7351--6.8810,749,690.004.754.435.425.2918.1519.686.475.49--3.270.78680.0025.0526.7749.9535.4787.38--
StemCell Institute Inc2.48bn310.98m17.08bn92.0054.936.3449.886.8830.3530.35242.15262.780.401722.191.82--5.034.2312.0510.8563.5164.4012.5310.411.19--0.00330.0018.6416.6357.0416.8446.68--
CellSource Co Ltd4.62bn851.00m25.25bn151.0029.044.2427.185.4643.9143.91237.98300.970.8246.0213.4830,626,030.0015.1619.2316.7122.5768.5370.7518.4020.218.20--0.0012.895.5430.04-9.3036.7070.54--
Falco Holdings Co Ltd43.01bn1.67bn25.62bn1.16k15.280.948112.780.5957151.32151.323,894.772,438.541.1420.606.67--4.435.795.757.9530.0531.283.884.662.29--0.030430.17-8.33-0.5259-26.3220.600.893711.70
I'rom Group Co Ltd17.74bn1.42bn34.35bn894.0023.822.6419.141.94116.87116.871,465.201,054.900.490913.335.02--3.926.945.979.8742.3143.177.9811.341.18--0.609829.64-3.3310.89-44.349.1816.6114.87
Gakken Holdings Co Ltd176.45bn3.73bn43.87bn9.49k11.560.79085.580.248785.0785.074,026.331,243.071.309.956.4018,592,940.003.102.614.873.9928.1029.172.381.951.1516.990.437333.865.188.93-7.150.8741-7.847.39
CUC Inc33.02bn2.60bn45.83bn2.99k17.151.6410.381.3989.0989.091,135.93931.800.6438294.863.89--5.08--7.24--48.21--7.90--2.09--0.4883---6.21--7.10------
Charm Care Corp44.99bn3.93bn50.57bn2.00k12.883.1010.501.12120.02120.021,375.72499.010.99594.4915.2322,537,580.008.697.1316.9510.7218.0117.388.737.860.7114104.060.508620.3330.3222.798.6239.0916.0254.49
Sunwels Co Ltd21.36bn2.03bn92.14bn1.75k39.1311.0845.684.3166.8566.85702.80236.170.84211,154.056.41--8.02--10.23--30.07--9.52--0.96935.500.7379--55.72--159.16------
Data as of May 31 2024. Currency figures normalised to CellSource Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

7.76%Per cent of shares held by top holders
HolderShares% Held
Baillie Gifford & Co.as of 30 Apr 2024516.11k2.61%
Nikko Asset Management Co., Ltd.as of 10 May 2024255.80k1.29%
Nomura Asset Management Co., Ltd.as of 30 Apr 2024218.50k1.10%
Daiwa Asset Management Co. Ltd.as of 30 Apr 2024144.60k0.73%
Asset Management One Co., Ltd.as of 09 May 2024105.10k0.53%
Wellington Management Co. LLPas of 31 Jan 202476.30k0.39%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202459.40k0.30%
Meiji Yasuda Asset Management Co. Ltd.as of 12 Aug 202259.00k0.30%
Jackson National Asset Management LLCas of 31 Mar 202451.10k0.26%
SBI Asset Management Co., Ltd.as of 22 Jun 202350.50k0.26%
More ▼
Data from 22 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.